Evans et al. (6, 8) reported that in vitro activated monocytes, or in vivo activated monocytes from synovial fluid (SF) of RA patients, preferentially promoted Th17 responses in CD4+ Tm cells. The gene discussed is CD4; the disease is rheumatoid arthritis.